4.6 Review

Linking RAGE and Nox in diabetic micro- and macrovascular complications

Journal

DIABETES & METABOLISM
Volume 41, Issue 4, Pages 272-281

Publisher

MASSON EDITEUR
DOI: 10.1016/j.diabet.2015.01.006

Keywords

Diabetes mellitus; Vascular complications; Atherosclerosis; Nephropathy; Oxidative stress; NADPH oxidases; Glycation; RAGE

Funding

  1. National Health and Medical Research Council of Australia (NHMRC) [GNT586676, 1044097, 1059124]
  2. Australian Diabetes Society Skip Martin Early Career Fellowship
  3. NHMRC Australian Biomedical Fellowship [472698]
  4. National Health and Medical Research Council of Australia [1059124] Funding Source: NHMRC

Ask authors/readers for more resources

Diabetes-associated micro- and macrovascular complications contribute to the increased morbidity and mortality observed in diabetes. Diabetes leads to accelerated generation of advanced glycation end products (AGEs) and activation of their receptor, RAGE, as well as activation of NAD(P)H oxidase (Nox), an enzyme dedicated to the production of reactive oxygen species, which ultimately leads to a pro-inflammatory environment characterised by oxidative stress. This review outlines the current evidence about the contribution of and interaction between the AGE-RAGE axis and Nox derived ROS formation in the development and progression of micro- and macrovascular diabetic complications (especially in atherosclerosis and nephropathy), and the mechanisms by which this occurs. We also outline novel treatments targeting the AGE-RAGE axis and specific Nox isoforms, which hold great promise in attenuating the development of diabetes-associated atherosclerosis and diabetic nephropathy. (C) 2015 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available